Blade Air Mobility Inc (BLDE)

$4.73 +0.15 (3.28%)
Market Cap 386.42M
Revenue (ttm) 248.69M
Net Income (ttm) -27.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10.98%
Debt to Equity Ratio 0.00
Volume 619,000
Avg Vol 1,204,030
Day's Range N/A - N/A
Shares Out 81.70M
Stochastic %K 96%
Beta 1.69
Analysts Strong Sell
Price Target $5.83

Company Profile

Blade Air Mobility, Inc. provides air transportation and logistics services for hospitals in the United States and internationally. The company operates in Passenger and Medical segments. It operates helicopter and amphibious seaplane flights in the United States and Europe; offers non-medical jet charter services; and transports human organs for transplant and/or the medical teams, as well as offers donor logistics coordination and support services. The company was founded in 2014 and is headqu...

Industry: Airports & Air Services
Sector: Industrials
Phone: 212 967 1009
Address:
31 Hudson Yards, 14th Floor, New York, United States
StocktwitsEarnings
StocktwitsEarnings Mar. 3 at 1:46 PM
$BLDE Q4 '25 Earnings Results & Recap Strata raised its full year 2026 revenue guidance to between $260M and Adjusted EBITDA guidance to between $29M, reflecting an improved outlook for the company's financial performance.
0 · Reply
topstockalerts
topstockalerts Mar. 3 at 1:13 PM
$BLDE here it comes… 🚨
0 · Reply
mikesterz7
mikesterz7 Mar. 3 at 12:49 PM
$BLDE 🚨 🚨 🚨 Revenue: $70.8 million, exceeding analysts' expectations of $64.09 million. This represents a 4.2% increase from Q2 2024. Earnings Per Share (EPS): -$0.05, missing the consensus estimate of -$0.04 by $0.01. This is an improvement over the $0.15 loss in Q2 2024. Net Loss: $3.74 million, a 67% reduction in loss compared to Q2 2024. Cash Position: The company ended Q2 2025 with $113.4 million in cash and short-term investments. Medical Division Growth: Medical revenue increased 17.6% year-over-year to $45.1 million. Passenger Division Divestiture: Blade is selling its passenger business to Joby Aviation for up to $125 million, allowing the company to focus on its higher-margin medical division, which will be rebranded as Strata Critical Medical. 2025 Guidance: Reaffirmed 2025 guidance of $245–265 million in revenue.
0 · Reply
mali221183
mali221183 Feb. 2 at 5:33 PM
$BLDE on way to zero?
0 · Reply
Mike1110
Mike1110 Jan. 12 at 8:26 PM
$BLDE $PL
0 · Reply
AnnaKan
AnnaKan Jan. 2 at 7:20 PM
$SRFM will be adding on the drops .. recent PR sounds promising for 2026! $BLDE $ACHR $JOBY https://investors.surfair.com/news/news-details/2025/Surf-Air-Mobility-Advances-SurfOS-Development-Targets-Commercial-Software-Rollout-in-2026-and-Reports-Milestones/default.aspx
0 · Reply
Mike1110
Mike1110 Dec. 24 at 3:35 AM
$ACHR $BLDE $JOBY $LILMF
0 · Reply
Mike1110
Mike1110 Dec. 24 at 3:34 AM
$ACHR $BLDE $EH $JOBY $LILMF
0 · Reply
Mike1110
Mike1110 Dec. 24 at 3:33 AM
$ACHR $BLDE $EH $JOBY $LILMF I was off 4 years but I definitely think it’s gonna be in . 2026
0 · Reply
Mike1110
Mike1110 Dec. 24 at 3:33 AM
$ACHR $BLDE $EH $JOBY $LILMF
1 · Reply
Latest News on BLDE
No data available.
StocktwitsEarnings
StocktwitsEarnings Mar. 3 at 1:46 PM
$BLDE Q4 '25 Earnings Results & Recap Strata raised its full year 2026 revenue guidance to between $260M and Adjusted EBITDA guidance to between $29M, reflecting an improved outlook for the company's financial performance.
0 · Reply
topstockalerts
topstockalerts Mar. 3 at 1:13 PM
$BLDE here it comes… 🚨
0 · Reply
mikesterz7
mikesterz7 Mar. 3 at 12:49 PM
$BLDE 🚨 🚨 🚨 Revenue: $70.8 million, exceeding analysts' expectations of $64.09 million. This represents a 4.2% increase from Q2 2024. Earnings Per Share (EPS): -$0.05, missing the consensus estimate of -$0.04 by $0.01. This is an improvement over the $0.15 loss in Q2 2024. Net Loss: $3.74 million, a 67% reduction in loss compared to Q2 2024. Cash Position: The company ended Q2 2025 with $113.4 million in cash and short-term investments. Medical Division Growth: Medical revenue increased 17.6% year-over-year to $45.1 million. Passenger Division Divestiture: Blade is selling its passenger business to Joby Aviation for up to $125 million, allowing the company to focus on its higher-margin medical division, which will be rebranded as Strata Critical Medical. 2025 Guidance: Reaffirmed 2025 guidance of $245–265 million in revenue.
0 · Reply
mali221183
mali221183 Feb. 2 at 5:33 PM
$BLDE on way to zero?
0 · Reply
Mike1110
Mike1110 Jan. 12 at 8:26 PM
$BLDE $PL
0 · Reply
AnnaKan
AnnaKan Jan. 2 at 7:20 PM
$SRFM will be adding on the drops .. recent PR sounds promising for 2026! $BLDE $ACHR $JOBY https://investors.surfair.com/news/news-details/2025/Surf-Air-Mobility-Advances-SurfOS-Development-Targets-Commercial-Software-Rollout-in-2026-and-Reports-Milestones/default.aspx
0 · Reply
Mike1110
Mike1110 Dec. 24 at 3:35 AM
$ACHR $BLDE $JOBY $LILMF
0 · Reply
Mike1110
Mike1110 Dec. 24 at 3:34 AM
$ACHR $BLDE $EH $JOBY $LILMF
0 · Reply
Mike1110
Mike1110 Dec. 24 at 3:33 AM
$ACHR $BLDE $EH $JOBY $LILMF I was off 4 years but I definitely think it’s gonna be in . 2026
0 · Reply
Mike1110
Mike1110 Dec. 24 at 3:33 AM
$ACHR $BLDE $EH $JOBY $LILMF
1 · Reply
Mike1110
Mike1110 Dec. 22 at 9:08 PM
$BLDE $PL
0 · Reply
NeedToQuitMyJob
NeedToQuitMyJob Nov. 6 at 1:06 PM
$BLDE So weird to see Blade news being released by Joby yhese days 😏
0 · Reply
MajorBigBull
MajorBigBull Oct. 27 at 3:54 PM
$BLDE
0 · Reply
MajorBigBull
MajorBigBull Oct. 6 at 4:47 PM
$BLDE soon
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 3 at 5:53 AM
@JoeyRockets @Stocktwits -Joey, there are several symbols listed on ST that are duplicates. You may want to merge them. Blade Air Mobile $BLDE is now Strata Critical Medical $SRTA. These two are the same. There was another with 3 symbols, but I can't find it right now. I'll let you know when I do.
1 · Reply
SmashBro
SmashBro Sep. 29 at 2:47 AM
$BLDE FDA Approval for OrganOx and a deal with Strata Critical Medical in this article: https://stkt.co/PUOmRO_w
0 · Reply
ragingOx
ragingOx Sep. 23 at 12:53 AM
$SRTA $BLDE $PLTR
0 · Reply
WOLFSTREET
WOLFSTREET Sep. 21 at 3:51 PM
$SRTA 129 followers? LOL ST forgot to transfer $BLDE followers over, AI cannot cure that, only hardcore IT can. CC is built on hardcore IT, so you can go AI (ALL-IN) on the best of the best based only on unique data built within the CC platform, this is like $PLTR for the stock market. You either beileve and have it or you don't. Go head, keep drawing silly lines with your crayolas. The new LISTVU will have a massive set of search criteria along with the ne report minification. CC launch still set for EOY, you won;t want to miss out because my posts will then, mostly cover after the run.
1 · Reply
JoeCoolTrader
JoeCoolTrader Sep. 19 at 8:28 PM
Buy $SRTA , short $BLDE 😂 $SPY
1 · Reply
SmashBro
SmashBro Sep. 19 at 7:52 AM
$BLDE https://www.biospace.com/press-releases/organox-metra-receives-fda-approval-for-operation-during-air-transport-expanding-access-to-life-saving-liver-perfusion-technology
0 · Reply
JoeCoolTrader
JoeCoolTrader Sep. 19 at 12:33 AM
@michaelbozzello @Stocktwits - I don't if you are aware, but $BLDE changed their name to $SRTA. I think it's confusing to maintain two separate feeds for the same company.
0 · Reply
Shazm
Shazm Sep. 18 at 5:07 PM
$BLDE yippppppeeeeee!!!!lets gooooooo
0 · Reply